Back to BT Blue Trust, Inc.
TGTX
Showing 8 of 15 quarters
Position history for BTBlue Trust, Inc.'s holdings in TG Therapeutics, Inc.
Yes. Blue Trust holds 3 shares of TGTX (TG Therapeutics), worth $167, as of its Q3 2026 13F filing. It reduced the position by 191 shares (-98.5%) from Q2 2026. Blue Trust has held TGTX since Q2 2024, across 10 quarterly 13F filings.
Current Value
$167
Current Shares
3
Total Value Change
-$56,632
Total Shares Change
-1,884
Quarter-by-Quarter History